New data from Phase 2a clinical trial evaluating atebimetinib + mGnP in first-line pancreatic cancer will be presented in an oral session by ...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
Anthropic (ANTHRO) has acquired Coefficient Bio, a biotech focused on developing AI models for biological research, for slightly more than $400M, according to The Information and a report from Eric ...
Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m New co-lead investor Biovance Capital and existing co-lead investor Kurma Partners ...
Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.
AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI biotech startup Coefficient Bio in a $400 million stock deal, according to ...
Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio, a specialist in applying AI to drug discovery that was set up last year, but until now has ...
Oral dosing of laboratory animals is not only a labor-intensive task for technicians, but is also stressful and potentially hazardous to the animals. Bio-Serv's MD's™ (Medicated Dosing System) and ...
Teemu Miettinen discusses his innovative method for measuring intracellular water, revealing its critical role in cell ...
The morning of my mother’s funeral, January 24, 1993, was just the type of morning she most loved, especially after a week of chill, gray days. Cold, crisp, and sparklingly clear, it was a day that ...
Enzymatic recycling pioneer Epoch Biodesign revealed today that it has closed a $12-million financing round that will accelerate the commercialisation of its recycled nylon 6,6. The investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results